NYSE:CRL
Charles River Laboratories International Stock News
$221.61
-3.14 (-1.40%)
At Close: May 17, 2024
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
08:00am, Thursday, 11'th Apr 2024
WILMINGTON, Mass. & DUBLIN--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River and Deciphex launch Patholytix Foresight, an AI-powered decision support tool for toxicologic pathology.
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
08:00am, Tuesday, 09'th Apr 2024
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration wi
Charles River to Perform Plasmid Production for Ship of Theseus
08:00am, Thursday, 04'th Apr 2024
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus, a therapeutics company developing degradation-resistant homeobox (HOX) family biolog
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
08:00am, Wednesday, 27'th Mar 2024
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the publication of its 2023 Corporate Citizenship Report, which includes progress and res
Charles River (CRL) Extends Gene Therapy Deal With NUS Medicine
10:41am, Tuesday, 26'th Mar 2024
Charles River (CRL) announces the extension of the gene therapy manufacturing alliance with NUS Medicine.
Why Is Charles River (CRL) Up 6.2% Since Last Earnings Report?
12:36pm, Friday, 15'th Mar 2024
Charles River (CRL) reported earnings 30 days ago. What's next for the stock?
Charles River (CRL) Extends Gene Therapy Offering With New Pact
11:31am, Friday, 15'th Mar 2024
Charles River's (CRL) partnership with Navega Therapeutics will enable it to leverage its strong AAV portfolio and leading gene therapy CDMO capabilities.
Here's Why You Should Retain Charles River (CRL) Stock Now
10:51am, Thursday, 14'th Mar 2024
Investors remain optimistic about Charles River (CRL) due to the strength of the RMS segment.
Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy Summit
04:00pm, Wednesday, 13'th Mar 2024
SOUTH SAN FRANCISCO, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Epic Bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that Amber Salzman
The Top 3 Healthcare Stocks to Buy in March 2024
12:27pm, Thursday, 07'th Mar 2024
Stock markets are reaching new highs and exuberance is in the air. For value investors, this might seem like a perplexing time.
Charles River (CRL) Forges Collaboration With Wheeler Bio
09:46am, Monday, 26'th Feb 2024
Charles River (CRL) and Wheeler Bio join forces to accelerate the journey from discovery and CMC development to manufacturing.
Charles River (CRL) Gains From CRADL Amid Soft Market Scenario
11:41am, Wednesday, 21'st Feb 2024
Within DSA, Charles River (CRL) is currently the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.
Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript
01:19pm, Wednesday, 14'th Feb 2024
Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript
Charles River (CRL) Q4 Earnings Surpass, Margins Contract
10:31am, Wednesday, 14'th Feb 2024
Charles River (CRL) delivers better-than-expected revenues and earnings in the fourth quarter of 2023.
Here's Why You Should Retain Charles River (CRL) Stock Now
09:21am, Tuesday, 13'th Feb 2024
Charles River's (CRL) share price is likely to grow, backed by the strength of the RMS segment.
